Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Sosei Group Corporation
Sosei Group Corporation
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Metrion and Sosei Heptares to explore structure-based drug design
Sosei Heptares will have exclusive global rights to all molecules identified
Research & Development
Sosei Heptares and PharmEnable enter drug discovery collaboration
The companies will jointly conduct and share the costs of the discovery and development program and will co-own any resulting products
Research & Development
Sosei Heptares announces €40 million Medicxi investment
Two asset-centric companies have been formed to develop Sosei’s novel therapies for neurological diseases funded by Medicxi
Recruitment
Sosei appoints Interim CFO
Media
Changes in executive management at Sosei
Manufacturing
Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017
Finance
Heptares Therapeutics enters agreement with Daichi Sankyo
The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Subscribe now